Screening for neuroblastoma in France: Methodological aspects and preliminary observations

Medical and Pediatric Oncology

Volumn 28, Issue 2, 1997, Pages 81-91

  Chauvin, F ^a   Mathieu, P ^a   Frappaz, D ^a   Lasset, C ^a   Favrot, M C ^a   Greffe, J ^a   Esteve, J ^a   Thiesse, P ^a   Combaret, V ^a   Chauvot, P ^a   Boschetti, R ^a   David, L ^a   Brunat Mentigny, M ^a   Philip, T ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

catecholamines; HPLC; neuroblastoma; pediatric oncology; screening

Indexed keywords

CATECHOLAMINE; CREATININE; HOMOVANILLIC ACID; VANILMANDELIC ACID;

ARTICLE; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; FRANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MASS SCREENING; NEUROBLASTOMA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS;

CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEASIBILITY STUDIES; FRANCE; HOMOVANILLIC ACID; HUMANS; INFANT; MASS SCREENING; NEOPLASM STAGING; NEUROBLASTOMA; PILOT PROJECTS; SENSITIVITY AND SPECIFICITY; VANILMANDELIC ACID;

EID: 0031023992     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199702)28:2<81::AID-MPO1>3.0.CO;2-O     Document Type: Article

References (37)